Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study
Zara Izadi(University of California, San Francisco), Philip C Robinson(The University of Queensland), K. Shidara, Tiffany Taylor(University of California, San Francisco), Saskia Lawson‐Tovey(Manchester Academic Health Science Centre), Jeffrey A. Sparks(Brigham and Women's Hospital), Anja Strangfeld(German Rheumatism Research Centre), Alí Duarte‐García(Mayo Clinic in Arizona), Naomi J. Patel(Evidence (Italy)), Yohana Tissera(Servicio Diabetología Hospital Córdoba), Guillermo Pons‐Estel(Hospital Provincial de Rosario), Manuel F. Ugarte‐Gil(Universidad Científica del Sur), Leanna Wise(University of Southern California), Samar Al‐Emadi(Hamad Medical Corporation), Cláudia Diniz Lopes Marques(Universidade Federal de Pernambuco), Kimme L Hyrich(Manchester Royal Infirmary), P. Cacoub(Sorbonne Université), Gabriela Schmajuk(San Francisco VA Medical Center), Cecilia Pisoni(Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno), Gecilmara Salviato Pileggi(Universidade Federal de São Carlos), Romina Tanten(Hospital Italiano de Buenos Aires), Milena Gianfrancesco(Pfizer (United States)), Patricia Katz(University of California, San Francisco), Lianne Kearsley‐Fleet(University of Manchester), Emily Gilbert(Jacksonville College), Christophe Richez(Centre National de la Recherche Scientifique), Carlo Alberto Scirè(Azienda Ospedaliera San Gerardo), Rebecca Hasseli(Kerckhoff Klinik), Elsa F Mateus(Portuguese League Against Epilepsy), Greta Carrara(Società Italiana di Reumatologia), Anne C. Regierer(German Rheumatism Research Centre), Romina Nieto(Hospital Provincial de Rosario), María José Santos(University of Lisbon), Hendrik Schulze‐Koops(LMU Klinikum), Lotta Ljung(Karolinska Institutet), Ricardo Machado Xavier(Universidade Federal do Rio Grande do Sul), Maria I. Danila(University of Alabama at Birmingham), Laure Gossec(Inserm), Thierry Thomas(Centre Hospitalier Universitaire de Saint-Étienne), Katherine D. Wysham(University of Washington), Loreto Carmona(Instituto de Salud Musculoesquelética), Martin Schaefer(German Rheumatism Research Centre), Stephanie Rush(University of California, San Francisco), Clairissa Ja(University of California, San Francisco), Lindsay Jacobsohn(University of California, San Francisco), Miguel Bernardes(Hospital de São João), Ulf Müller-Ladner, Tiffany Hsu(Baylor College of Medicine), Eric Hachulla(Inserm), Maria O Valenzuela-Almada(Mayo Clinic)
Cited by 19
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
2022 update
|Radboud Repository (Radboud University)|2010|1.6k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
|New England Journal of Medicine|2019|1.3k